{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:55:14Z","timestamp":1700492114434},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.ijantimicag.2007.09.011","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T11:57:32Z","timestamp":1196942252000},"page":"177-179","source":"Crossref","is-referenced-by-count":2,"title":["Meropenem-aggravated seizure activity in progressive myoclonus epilepsy"],"prefix":"10.1016","volume":"31","author":[{"given":"Ioannis G.","family":"Baraboutis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markos N.","family":"Marangos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Skoutelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralambos","family":"Bassaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.09.011_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.1575","article-title":"Advances in the genetics of progressive myoclonus epilepsy","volume":"106","author":"Delgado-Escueta","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ijantimicag.2007.09.011_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/AAC.39.1.232","article-title":"Relationship between structure and convulsant properties of some \u03b2-lactam antibiotics following intracerebroventricular microinjection in rats","volume":"39","author":"de Sarro","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2007.09.011_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jac\/36.suppl_A.207","article-title":"Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem","volume":"36","author":"Norrby","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.09.011_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00003246-199710000-00015","article-title":"Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study","volume":"25","author":"Sieger","year":"1997","journal-title":"Crit Care Med"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2007.09.011_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/36.suppl_A.85","article-title":"A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults","volume":"36","author":"Schmutzhard","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.09.011_bib6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/AAC.39.5.1140","article-title":"Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis","volume":"39","author":"Klugman","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.09.011_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2007.09.011_bib8","first-page":"167","article-title":"Meropenem in elderly and renally impaired patients","volume":"11","author":"Cunha","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.09.011_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(83)90749-3","article-title":"\u2018Baltic\u2019 myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin","volume":"2","author":"Eldridge","year":"1983","journal-title":"Lancet"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T02:24:27Z","timestamp":1546395867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907004840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0924857907004840"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.09.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}